Functional Mechanism(s) of the Inhibition of Disease Progression by Combination Treatment with Fingolimod Plus Pathogenic Antigen in a Glucose-6-phosphate Isomerase Peptide-Induced Arthritis Mouse Model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Functional Mechanism(s) of the Inhibition of Disease Progression by Combination Treatment with Fingolimod Plus Pathogenic Antigen in a Glucose-6-phosphate Isomerase Peptide-Induced Arthritis Mouse Model

Published:2015 Issue:8 Volume:38 Page:1120-1125
ISSN:0918-6158
Container-title:Biological & Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Yoshida Yuya¹,Mikami Norihisa²,Matsushima Yuki¹,Otani Fumiya¹,Miyawaki Mai¹,Takatsuji Miku²,Banno Rie¹,Tsuji Takumi¹,Fujita Tetsuro³,Tsujikawa Kazutake²,Kohno Takeyuki¹³

Affiliation:

1. Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Setsunan University

2. Laboratory of Molecular and Cellular Physiology, Graduate School of Pharmaceutical Sciences, Osaka University

3. Research Institute for Production and Development

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/38/8/38_b14-00873/_pdf

Reference34 articles.

1. 1) Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet, 376, 1094–1108 (2010).

2. 2) Gumanovskaya ML, Myers LK, Rosloniec EF, Stuart JM, Kang AH. Intravenous tolerization with type II collagen induces interleukin-4- and interleukin-10-producing CD4⁺ T cells. Immunology, 97, 466–473 (1999).

3. 3) Li H, Ciric B, Yang J, Xu H, Fitzgerald DC, Elbehi M, Fonseca-Kelly Z, Yu S, Zhang GX, Rostami A. Intravenous tolerance modulates macrophage classical activation and antigen presentation in experimental autoimmune encephalomyelitis. J. Neuroimmunol., 208, 54–60 (2009).

4. 4) Jiang Z, Li H, Fitzgerald DC, Zhang GX, Rostami A. MOG_35–55 i.v. suppresses experimental autoimmune encephalomyelitis partially through modulation of Th17 and JAK/STAT pathways. Eur. J. Immunol., 39, 789–799 (2009).

5. 5) Yoshida Y, Tsuji T, Watanabe S, Matsushima A, Matsushima Y, Banno R, Fujita T, Kohno T. Efficacy of combination treatment with fingolimod (FTY720) plus pathogenic autoantigen in a glucose-6-phosphate isomerase peptide (GPI_325–339)-induced arthritis mouse model. Biol. Pharm. Bull., 36, 1739–1746 (2013).

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Strategy for Rheumatoid Arthritis by Induction of Myeloid-Derived Suppressor Cells with High Suppressive Potential;Biological and Pharmaceutical Bulletin;2022-08-01

2. Characterization of an Expanded IL-10-Producing-Suppressive T Cell Population Associated with Immune Tolerance;Biological and Pharmaceutical Bulletin;2021-04-01

3. Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders;Therapeutic Advances in Neurological Disorders;2021-01

4. Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice;Journal of Visualized Experiments;2020-01-31

5. Combination treatment with fingolimod and a pathogenic antigen prevents relapse of glucose‐6‐phosphate isomerase peptide‐induced arthritis;Immunity, Inflammation and Disease;2016-06-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3